Overall weakness in all key segments (PCNO, VAHO and Saffola) is underwhelming and likely to persist for one more quarter, in our view. However, by H2, the impact of price-deflation on overall portfolio is likely to subside (likely positive revenue growth). Unlike peers, MRCO calls out for no clear signs of rural recovery (sequentially): as GT continues to under-perform (~6% revenue decline).